Research Article
Virulence Factors and Antimicrobial Resistance of Uropathogenic Escherichia coli EQ101 UPEC Isolated from UTI Patient in Quetta, Balochistan, Pakistan
| CLSI zone sizes | Antibiotic | Sensitive ≥ | Intermediate | Resistant ≤ | EQ101 |
| Amoxicillin and clavulanate (30 μg) | 18 | 14-17 | 13 | 18 | Ampicillin (10 μg) | 17 | 14-16 | 13 | 0 | Amikacin (30 μg) | 17 | 15-16 | 14 | 21 | Aztreonam (30 μg) | 21 | 18-20 | 17 | 23 | Gentamicin (10 μg) | 15 | 13-14 | 12 | 15 | Ceftriaxone (30 μg) | 23 | 20-22 | 19 | 0 | Nitrofurantoin (300 μg) | 17 | 15-16 | 14 | 20 | Nalidixic acid (30 μg) | 19 | 14-18 | 13 | 6 | Trimethoprim (25 μg) | 16 | 11-15 | 10 | 17 | Cefixime (5 μg) | 19 | 16-18 | 15 | 0 | Fosfomycin (50 μg) | 16 | 13-15 | 12 | 22 | Ciprofloxacin (5 μg) | 31 | 21-30 | 20 | 0 | Piperacillin/tazobactam (40 μg) | 21 | 18-20 | 17 | 21 | Ertapenem (10 μg) | 22 | 19-21 | 18 | 22 | Ofloxacin (5 μg) | 16 | 13-15 | 12 | 8 |
|
|